Clinical Roundup Axi-cel proves effective as first-line treatment for high-risk lymphoma March 25, 2022Vol.48 No.12
Clinical Roundup MD Anderson researchers’ tool enables spatial mapping of single-cell data within tissues March 25, 2022Vol.48 No.12
Clinical Roundup OSUCCC program aims to reduce inequities in colon cancer rates by mailing at-home screening kits to Black patients March 25, 2022Vol.48 No.12
Clinical Roundup UPMC study supports shortened quarantine period among asymptomatic healthcare professionals exposed to SARS-CoV-2 March 25, 2022Vol.48 No.12
Clinical Roundup ECOG-ACRIN opens NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations March 18, 2022Vol.48 No.11
Clinical Roundup University of Pittsburgh study finds malaria drug could combat chemotherapy-resistant head and neck cancers March 18, 2022Vol.48 No.11
Clinical Roundup OSUCCC – James study highlights impact of intersecting identities in cancer risk March 18, 2022Vol.48 No.11
Clinical Roundup Yale study identifies class of oncogenic fusions in lung and pancreatic cancer March 18, 2022Vol.48 No.11
Clinical Roundup Yale scientists discover pathogenic mechanism in hematological malignancies March 18, 2022Vol.48 No.11
Clinical Roundup Researchers measure drop in cancer detection in Ontario due to COVID-19 March 18, 2022Vol.48 No.11
